3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Hepatoblastoma
1
Hemangioma, Cavernous, Central Nervous System
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Interventions
Sirolimus
3
Melphalan
3
Granulocyte Colony-Stimulating Factor
3
Cyclophosphamide
3
Automobiles
3
pembrolizumab
2
fludarabine
2
etoposide phosphate
2
Stem Cell Transplantation
2
Mesna
2
Immunotherapy
2
Gemcitabine
2
Etoposide
2
Carboplatin
2
Busulfan
2
vorasidenib
1
trametinib
1
tozuleristide
1
sonidegib
1
sodium thiosulfate
1
ripretinib
1
ribociclib
1
pegylated granulocyte colony-stimulating factor
1
lutetium Lu 177 dotatate
1
interferon gamma-1b
1
fludarabine phosphate
1
Watchful Waiting
1
Vorinostat
1
Ursodeoxycholic Acid
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Simvastatin
×
CNS
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled